Cite
Dobroff AS, Rodrigues EG, Juliano MA, et al. Differential Antitumor Effects of IgG and IgM Monoclonal Antibodies and Their Synthetic Complementarity-Determining Regions Directed to New Targets of B16F10-Nex2 Melanoma Cells. Transl Oncol. 2010;3(4):204-17doi: 10.1593/tlo.09316.
Dobroff, A. S., Rodrigues, E. G., Juliano, M. A., Friaça, D. M., Nakayasu, E. S., Almeida, I. C., Mortara, R. A., Jacysyn, J. F., Amarante-Mendes, G. P., Magliani, W., Conti, S., Polonelli, L., & Travassos, L. R. (2010). Differential Antitumor Effects of IgG and IgM Monoclonal Antibodies and Their Synthetic Complementarity-Determining Regions Directed to New Targets of B16F10-Nex2 Melanoma Cells. Translational oncology, 3(4), 204-17. https://doi.org/10.1593/tlo.09316
Dobroff, Andrey S, et al. "Differential Antitumor Effects of IgG and IgM Monoclonal Antibodies and Their Synthetic Complementarity-Determining Regions Directed to New Targets of B16F10-Nex2 Melanoma Cells." Translational oncology vol. 3,4 (2010): 204-17. doi: https://doi.org/10.1593/tlo.09316
Dobroff AS, Rodrigues EG, Juliano MA, Friaça DM, Nakayasu ES, Almeida IC, Mortara RA, Jacysyn JF, Amarante-Mendes GP, Magliani W, Conti S, Polonelli L, Travassos LR. Differential Antitumor Effects of IgG and IgM Monoclonal Antibodies and Their Synthetic Complementarity-Determining Regions Directed to New Targets of B16F10-Nex2 Melanoma Cells. Transl Oncol. 2010 Aug 01;3(4):204-17. doi: 10.1593/tlo.09316. PMID: 20689762; PMCID: PMC2915412.
Copy
Download .nbib